title: Chemotherapy-induced bullous acral erythema in a subject with B-cell lymphoma.
authors.forename: M
authors.initials: M
authors.lastname: Soker
authors.forename: S
authors.initials: S
authors.lastname: Akdeniz
authors.forename: C
authors.initials: C
authors.lastname: Devecioglu
authors.forename: K
authors.initials: K
authors.lastname: Haspolat
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002648:Child; D003561:Cytarabine / Q000008:administration & dosage; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology*; D004890:Erythema / Q000139:chemically induced; D005500:Follow-Up Studies; D006229:Hand Dermatoses / Q000139:chemically induced; D006801:Humans; D007262:Infusions, Intravenous; D016393:Lymphoma, B-Cell / Q000188:drug therapy* / Q000473:pathology*; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D009367:Neoplasm Staging; D018570:Risk Assessment; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced* / Q000175:diagnosis
chemical_list: D003561:Cytarabine; D008727:Methotrexate